AU2011100917A4 - Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens - Google Patents
Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens Download PDFInfo
- Publication number
- AU2011100917A4 AU2011100917A4 AU2011100917A AU2011100917A AU2011100917A4 AU 2011100917 A4 AU2011100917 A4 AU 2011100917A4 AU 2011100917 A AU2011100917 A AU 2011100917A AU 2011100917 A AU2011100917 A AU 2011100917A AU 2011100917 A4 AU2011100917 A4 AU 2011100917A4
- Authority
- AU
- Australia
- Prior art keywords
- daily
- minoxidil
- antiandrogens
- alone
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Abstract
Abstract Low dose oral minoxidil can be compounded into capsules and used either alone or in combination with oral antiandrogens therapy to promote scalp hair growth in androgenetic alopecia and other hair loss related disorders without usual side-effects vasodilatation, hypotension and hypertrichosis associated with standard doses.
Description
1 Description Oral minoxidil is a potent hair growth stimulant. Standard doses are associated with vasodilatation, hypotension and hypertrichosis. Low dose oral minoxidil can be compounded into capsules and used either alone or in combination with oral antiandrogens therapy to promote scalp hair regrowth in androgenetic alopecia and other hair loss related disorders. In males it can be used together with finasteride, dutasteride or other antiandrogen treatments. In females it can be used together with spironolactone, cyproterone acetate, flutamide and other antiandrogen therapies. Doses of oral minoxidil that have been tried in both men and women with hair loss include 0.5 mg daily, 1 mg daily, 2 mg daily, 2.5 mg daily, 3 mg daily, 5 mg daily and 10 mg daily. Other doses within this range are also likely to be effective. Doses of finasteride that have been tried in men include 0.5 mg daily, 1mg daily, 5 mg daily and 5 mg weekly. Dose of dutasteride that have been tried in men include 0.5mg daily ad 1 mg daily and 0.5 mg weekly. Doses of spironolactone that have been tried include 25 mg daily, 50 mg daily, 100mg daily, 200 mg daily, 300 mg daily and 400 mg daily. Doses of flutamide that have been tried include 25 mg daily, 50 mg daily, 62.5 mg daily, 100 mg daily, 125 mg daily, 250 mg daily and 500 mg daily. Doses of cyproterone acetate that have been tried include 2mg daily, 25 mg daily, 50 mg daily and 100 mg daily. These can also be combined with oral contraceptive therapy to minimize the risk of unplanned pregnancy while on this treatment.
Claims (1)
- 2.5mg minoxidil capsule 5mg minoxidil capsule 10mg minoxidil capsule 1mg minoxidil, 1mg finasteride capsule 1mg minoxidil 0.5 mg dutasteride capsule 1mg minoxidil 50 mg flutamide capsule 1mg minoxidil 62.5 mg flutamide capsule 2mg minoxidil, 1mg finasteride capsule 2mg minoxidil 0.5 mg dutasteride capsule 2mg minoxidil 50 mg flutamide capsule 2mg minoxidil 62.5 mg flutamide capsule 2.5mg minoxidil, 1mg finasteride capsule 2.5mg minoxidil 0.5 mg dutasteride capsule 2.5mg minoxidil 50 mg flutamide capsule 2.5mg minoxidil 62.5 mg flutamide capsule
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100917A AU2011100917B4 (en) | 2011-07-26 | 2011-07-26 | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100917A AU2011100917B4 (en) | 2011-07-26 | 2011-07-26 | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2011100917A4 true AU2011100917A4 (en) | 2011-09-01 |
| AU2011100917B4 AU2011100917B4 (en) | 2013-05-02 |
Family
ID=45421166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011100917A Expired AU2011100917B4 (en) | 2011-07-26 | 2011-07-26 | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2011100917B4 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3019045A1 (en) * | 2014-03-26 | 2015-10-02 | Greenpharma Sas | DERMATOLOGICAL COMPOSITION FOR THE REPELLENT OF HAIR OR HAIR |
| EP3209275A4 (en) * | 2014-10-24 | 2018-04-11 | Beautopia LLC | Combined hair loss inhibition treatment |
| US10226462B2 (en) | 2014-10-29 | 2019-03-12 | Samson Clinical Pty Ltd | Detection and treatment of excessive hair shedding |
| CN111065396A (en) * | 2017-07-12 | 2020-04-24 | 萨姆森临床私人有限公司 | Promoting hair growth and treating defective or excessive hair loss |
| WO2023055740A1 (en) * | 2021-09-29 | 2023-04-06 | Nirmana Bio, Inc. | Hair loss therapy |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109674762A (en) * | 2019-03-05 | 2019-04-26 | 南京正大天晴制药有限公司 | A kind of composition capsule of dutasteride and hair growth |
-
2011
- 2011-07-26 AU AU2011100917A patent/AU2011100917B4/en not_active Expired
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3019045A1 (en) * | 2014-03-26 | 2015-10-02 | Greenpharma Sas | DERMATOLOGICAL COMPOSITION FOR THE REPELLENT OF HAIR OR HAIR |
| EP3209275A4 (en) * | 2014-10-24 | 2018-04-11 | Beautopia LLC | Combined hair loss inhibition treatment |
| US10195199B2 (en) | 2014-10-24 | 2019-02-05 | Beautopia Llc | Combined hair loss inhibition treatment |
| US10744138B2 (en) | 2014-10-24 | 2020-08-18 | Garuhda Llc | Combined hair loss inhibition treatment |
| US10226462B2 (en) | 2014-10-29 | 2019-03-12 | Samson Clinical Pty Ltd | Detection and treatment of excessive hair shedding |
| US20190192513A1 (en) * | 2014-10-29 | 2019-06-27 | Samson Clinical Pty Ltd | Detection and Treatment of Excessive Hair Shedding |
| EP3626244A1 (en) * | 2014-10-29 | 2020-03-25 | Samson Clinical Pty Ltd. | Oral minoxidil for the treatment of alopecia areata |
| US11116770B2 (en) | 2014-10-29 | 2021-09-14 | Samson Clinical Pty Ltd | Detection and treatment of excessive hair shedding |
| CN115998740A (en) * | 2014-10-29 | 2023-04-25 | 萨姆森临床私人有限公司 | Detection and treatment of excessive hair loss |
| CN111065396A (en) * | 2017-07-12 | 2020-04-24 | 萨姆森临床私人有限公司 | Promoting hair growth and treating defective or excessive hair loss |
| WO2023055740A1 (en) * | 2021-09-29 | 2023-04-06 | Nirmana Bio, Inc. | Hair loss therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011100917B4 (en) | 2013-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011100917A4 (en) | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens | |
| US8372383B2 (en) | Agent for inducing hair growth containing extracts of saw palmetto and swertia | |
| IL183292A0 (en) | Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum | |
| MY129714A (en) | Preparations for topical administration of substances having antiandrogenic activity | |
| US8985124B2 (en) | Method for treatment of hair loss with a combination of natural ingredients | |
| EA200900491A1 (en) | USE OF ESTRADIOL VALERAT OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL TREATMENT TO MAINTAIN AND / OR INCREASE SEXUAL TREATMENT IN THE SPECIAL WOMAN | |
| WO2010013110A3 (en) | Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness | |
| JP2004500353A5 (en) | ||
| WO2017004692A1 (en) | Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth | |
| Rafi et al. | Pilot study of 15 patients receiving a new treatment regimen for androgenic alopecia: the effects of atopy on AGA | |
| US20120064174A1 (en) | Method for stimulating hair growth | |
| WO2005009456A3 (en) | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | |
| US20120258972A1 (en) | Composition and Methods for Treating Hair Loss | |
| US20080267899A1 (en) | Plant extract composition for hair growth | |
| EP3668482B1 (en) | Combination therapy for hair loss | |
| EP3511006B1 (en) | Composition for preventing, improving or treating hair loss comprising deoxycholic acid as active ingredient | |
| WO2008036054A3 (en) | Anti-hair loss and hair growth enhancer product | |
| US20150118292A1 (en) | Compositions and methods for treatment of hair loss | |
| TW201838642A (en) | Combination of aqueous extracts of watercress and of indian cress and atp in the treatment of alopecia | |
| Bunagan | Medical treatment of hair loss | |
| Lee | Topical treatment of pattern hair Loss | |
| 유박린 | Symposium 6-2 (SYP 6-2): Recent progress in male pattern hair loss: topical medical treatment | |
| Tab | t TINEA VERSICOLOR | |
| MX2018001546A (en) | Mx/a/2018/001546formulation and method for the treatment of androgenic alopecia. | |
| Aron-Brunetiere | Aspects of endocrinological treatment of hair diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGI | Letters patent sealed or granted (innovation patent) | ||
| FF | Certified innovation patent | ||
| MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |